Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-5198

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-5198). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 5198 3)

Atorvastatin Calcium 10 mg tablets label from NuCare Pharmaceuticals, Inc. The label indicates the product strength as 10 mg, dosage form as film-coated tablets, and a quantity of 30 tablets per container. It includes manufacturer details, the NDC number 68071-5198-3, and specifies the tablets as oval-shaped white/off-white debossed with 'FF1' on one side. The label also provides storage instructions and a warning to keep out of reach of children.*

FDA Label Image

Figure (Atorvastatin Calcium Figure 1)

A cumulative incidence line graph comparing Atorvastatin and Placebo over approximately 3.5 years. The y-axis represents cumulative incidence (%) and the x-axis represents time in years. The solid line indicates Atorvastatin, showing a lower cumulative incidence compared to the dashed line representing Placebo. The graph includes a hazard ratio (HR=0.64) with confidence interval (0.50-0.83) and a p-value of 0.0005.*

FDA Label Image

Figure (Atorvastatin Calcium Figure 2)

A Kaplan-Meier cumulative hazard plot comparing placebo and atorvastatin groups over a 5-year period. The x-axis shows time to first primary endpoint in years, and the y-axis shows cumulative hazard in percentage. The atorvastatin group displays a lower cumulative hazard than placebo, with a hazard ratio of 0.63 (95% CI 0.48-0.83, p=0.001).*

FDA Label Image

Figure (Atorvastatin Calcium Figure 3)

A Kaplan-Meier survival curve comparing subjects experiencing a major cardiovascular event over 5 years for Atorvastatin 10 mg and 80 mg doses. The y-axis shows the percentage of subjects experiencing the event, and the x-axis shows time in years to the first major cardiovascular endpoint. The graph includes a hazard ratio of 0.78 (95% CI 0.69-0.89) with a p-value of 0.0002 indicating statistical significance.*

FDA Label Image

Chemical Structure (Atorvastatin Calcium Structure)

Chemical structure diagram of atorvastatin calcium, showing its molecular formula including calcium ions (Ca2+) and three water molecules (3H2O). The structure features fluorophenyl, hydroxy, and carboxylate groups characteristic of atorvastatin calcium.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.